ROLE SUMMARY The Rare Endocrine portfolio comprises 2 products, Ngenla and Genotropin. Ngenla is a once-weekly pediatric growth hormone deficiency (pGHD) therapy that launched in June 2023 and is poised to become the anchor product of
Position Summary: The Manager of Utilization Management provides daily oversight for Case Management teams (which includes RN’s, Social Workers, and Coordinators). The Manager of Utilization Management is responsible for ensuring high quality, cost-effective, and appropriate allocation